Post by Reza Zahiri, PhD, MBA

VP Imaging & AI at DV | Prof at UBC | Author of Amazon Bestseller | Top 10 Canadian Content Creator | Visual Analytics | Business | Strategy | Leadership

π‚π„πŽπ¬ 𝐖𝐑𝐨 πƒπžπ₯𝐒𝐯𝐞𝐫𝐞𝐝 𝐭𝐑𝐞 𝐌𝐨𝐬𝐭 𝐌𝐚𝐫𝐀𝐞𝐭 π‚πšπ© 𝐆𝐫𝐨𝐰𝐭𝐑 𝐚𝐭 π„πšπœπ‘ π‚π¨π¦π©πšπ§π² Β  CEOs are often judged on strategy, innovation, culture, and operational execution. But no matter which leadership lens you prefer, public markets keep a brutally simple scoreboard: shareholder value creation. Some CEOs built value through steady and organic growth over long tenures, often supported by disciplined tuck-in acquisitions. Others created outsized value through bold portfolio moves, major M&A, restructurings, spin-offs, or business model shifts. Below is a look at the top CEOs of leading medical device companies that created the most shareholder value during their tenure (inflation-adjusted): β†’ Abbott: Miles D. White / Duane Burnham / Robert Ford / Robert Schoellhorn β†’ Medtronic: Bill George / Omar Ishrak β†’ Thermo Fisher Scientific: Marc Casper / Marjin Dekkers β†’ Intuitive: Gary Guthart / Lonnie Smith β†’ Danaher Corporation: Thomas Joyce / Larry Culp / Rainer Blair β†’ Boston Scientific: Mike Mahoney / Pete Nicholas β†’ Stryker: Kevin Lobo / John Brown β†’ BD: Vincent Forlenza / Edward Ludwig β†’ Baxter International Inc.: Robert Parkinson/ Vernon Loucks β†’ Edwards Lifesciences: Michael Mussallem β†’ Resmed: Michael "Mick" Farrell Farrell / Peter Farrell β†’ Guidant: Ron Dollens β†’ IDEXX: Jay Mazelsky β†’ Zimmer Biomet: Raymond Elliott / David Dvorak β†’ Dexcom: Kevin Sayer β†’ Philips: Roy Jakobs β†’ Siemens Healthineers: Bernd Montag β†’ Alcon: David Endicott β†’ Hologic, Inc.: Stephen MacMillan β†’ GE HealthCare: Peter J Arduini β†’ St. Jude Medical: Daniel Starks My recent MedTech book: https://lnkd.in/guXX8FUp My newsletter: rezazahiri.substack.com *Please share with credit. Do not crop, remove, or alter attribution. Views are my own. Content is all public data intended for educational purposes, not financial advice. I encourage readers to do their research.

Post content